JMJD3 acts in tandem with KLF4 to facilitate reprogramming to pluripotency

JMJD3 与 KLF4 协同作用,促进细胞重编程为多能干细胞。

阅读:9
作者:Yinghua Huang #,Hui Zhang #,Lulu Wang,Chuanqing Tang,Xiaogan Qin,Xinyu Wu,Meifang Pan,Yujia Tang,Zhongzhou Yang,Isaac A Babarinde,Runxia Lin,Guanyu Ji,Yiwei Lai,Xueting Xu,Jianbin Su,Xue Wen,Takashi Satoh,Tanveer Ahmed,Vikas Malik,Carl Ward,Giacomo Volpe,Lin Guo,Jinlong Chen,Li Sun,Yingying Li,Xiaofen Huang,Xichen Bao,Fei Gao,Baohua Liu,Hui Zheng,Ralf Jauch,Liangxue Lai,Guangjin Pan,Jiekai Chen,Giuseppe Testa,Shizuo Akira,Jifan Hu,Duanqing Pei,Andrew P Hutchins,Miguel A Esteban,Baoming Qin

Abstract

The interplay between the Yamanaka factors (OCT4, SOX2, KLF4 and c-MYC) and transcriptional/epigenetic co-regulators in somatic cell reprogramming is incompletely understood. Here, we demonstrate that the histone H3 lysine 27 trimethylation (H3K27me3) demethylase JMJD3 plays conflicting roles in mouse reprogramming. On one side, JMJD3 induces the pro-senescence factor Ink4a and degrades the pluripotency regulator PHF20 in a reprogramming factor-independent manner. On the other side, JMJD3 is specifically recruited by KLF4 to reduce H3K27me3 at both enhancers and promoters of epithelial and pluripotency genes. JMJD3 also promotes enhancer-promoter looping through the cohesin loading factor NIPBL and ultimately transcriptional elongation. This competition of forces can be shifted towards improved reprogramming by using early passage fibroblasts or boosting JMJD3's catalytic activity with vitamin C. Our work, thus, establishes a multifaceted role for JMJD3, placing it as a key partner of KLF4 and a scaffold that assists chromatin interactions and activates gene transcription.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。